Figure 2.
Rate of overall survival for patients with A. clinical IIIB/IIIC disease, B. clinical T3/T4 tumor, or C. pathologic T1/T2 tumor after NAC who were treated with PMRT and without PMRT.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.